Here's Why Novartis (NVS) is a Strong Value Stock
Yahoo Finance · 2 weeks ago
Open | 111.30 |
High | 111.71 |
Low | 110.78 |
Mkt Cap | 226.26B |
P/E (TTM) | 25.20 |
Div & Yield | 3.78 & 3.44% |
Prev. Close | 109.94 |
52 Wk. Low | 92.19 |
52 Wk. High | 111.71 |
Related stocks
Swiss-American multinational pharmaceutical corporation
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 12.12B | 9.70% ▲ |
Net Income | 2.69B | 17.20% ▲ |
Diluted EPS | 1.80 | 21.50% ▲ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $1.86 | - |
Q1 2024 | $1.69 | $1.80 |
Q4 2023 | $1.68 | $1.53 |
S&P 500^GSPC | 5,581.87-52.04 (-0.92%) |
Dow 30^DJI | 39,760.64+39.28 (+0.10%) |
Nasdaq^IXIC | 18,291.35-356.10 (-1.91%) |
7.00+29.39% | |
857.66-3.01% | |
5.42+6.87% |